About TMS
Helping Patients Gain a Better Understanding of TMS
Brainsway Deep TMS, was FDA-approved in 2013, and is a non-invasive, non-pharmaceutical treatment that uses magnetic pulses to stimulate the nerve cells in the brain that are responsible for depression, and is transforming the lives of patients who suffer from Major Depressive Disorder (MDD). 33% of MDD patients are resistant to any medication and 52% fail to respond to first-line therapy.
Accepted by Most Insurances
Most insurance companies pay for Deep TMS therapy if a person has a diagnosis of Major Depressive Disorder, Single Episode, Severe (F32.2) or Major Depressive Disorder, Recurrent, Severe (F33.2) and meets the medical necessity criteria specific to their insurance company. Our prior authorization team will work with your insurance company to make sure all necessary paperwork is completed before your first treatment.
Promising Hope for Other Brain Disorders
Deep TMS has multiple clinical trials and treatment protocols for disorders such as OCD, PTSD, Migraines, Bipolar Depression, Schizophrenia, Tinnitus, Parkinson’s, MS, and addictions, such as smoking, opiates, alcohol, and food cravings. It is being widely used in Europe to treat multiple disorders and has a CE designation for 13 indications.